| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 324,655788 | 29/12/2025 | 24,49% | 43,05% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 283,120000 | 29/12/2025 | 37,28% | 47,56% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.472,046575 | 29/12/2025 | 23,60% | 40,89% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.208,120000 | 29/12/2025 | 19,25% | 43,90% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C DIS EUR | RVI EMERGENTES | 747,170000 | 29/12/2025 | 16,31% | 33,37% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS C-H CAP USD | RVI EMERGENTES | 222,522523 | 29/12/2025 | 7,29% | 37,29% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS I CAP EUR | RVI EMERGENTES | 1.461,820000 | 29/12/2025 | 20,16% | 48,49% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS N CAP EUR | RVI EMERGENTES | 1.076,910000 | 29/12/2025 | 18,89% | 42,57% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS R CAP EUR | RVI EMERGENTES | 208,630000 | 29/12/2025 | 20,39% | 47,98% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS V CAP EUR | RVI EMERGENTES | 1.508,830000 | 29/12/2025 | 20,91% | 50,37% | **** |